525 related articles for article (PubMed ID: 24072779)
21. The role of T1 perfusion-based classification in magnetic resonance-guided high-intensity focused ultrasound ablation of uterine fibroids.
Keserci B; Duc NM
Eur Radiol; 2017 Dec; 27(12):5299-5308. PubMed ID: 28616725
[TBL] [Abstract][Full Text] [Related]
22. Mid-term clinical efficacy of a volumetric magnetic resonance-guided high-intensity focused ultrasound technique for treatment of symptomatic uterine fibroids.
Ikink ME; Voogt MJ; Verkooijen HM; Lohle PN; Schweitzer KJ; Franx A; Mali WP; Bartels LW; van den Bosch MA
Eur Radiol; 2013 Nov; 23(11):3054-61. PubMed ID: 23793518
[TBL] [Abstract][Full Text] [Related]
23. Noninvasive, in vivo determination of uterine fibroid thermal conductivity in MRI-guided high intensity focused ultrasound therapy.
Zhang J; Fischer J; Warner L; Oto A; Hor PH; Muthupillai R
J Magn Reson Imaging; 2015 Jun; 41(6):1654-61. PubMed ID: 25160768
[TBL] [Abstract][Full Text] [Related]
24. Preservation of the endometrial enhancement after magnetic resonance imaging-guided high-intensity focused ultrasound ablation of submucosal uterine fibroids.
Kim YS; Kim TJ; Lim HK; Rhim H; Jung SH; Ahn JH; Lee JW; Kim BG
Eur Radiol; 2017 Sep; 27(9):3956-3965. PubMed ID: 28210800
[TBL] [Abstract][Full Text] [Related]
25. Outcome of uterine artery embolization versus MR-guided high-intensity focused ultrasound treatment for uterine fibroids: long-term results.
Froeling V; Meckelburg K; Schreiter NF; Scheurig-Muenkler C; Kamp J; Maurer MH; Beck A; Hamm B; Kroencke TJ
Eur J Radiol; 2013 Dec; 82(12):2265-9. PubMed ID: 24075785
[TBL] [Abstract][Full Text] [Related]
26. Magnetic Resonance Imaging Parameters in Predicting the Treatment Outcome of High-intensity Focused Ultrasound Ablation of Uterine Fibroids With an Immediate Nonperfused Volume Ratio of at Least 90.
Keserci B; Duc NM
Acad Radiol; 2018 Oct; 25(10):1257-1269. PubMed ID: 29525424
[TBL] [Abstract][Full Text] [Related]
27. Enhancing ablation effects of a microbubble-enhancing contrast agent ("SonoVue") in the treatment of uterine fibroids with high-intensity focused ultrasound: a randomized controlled trial.
Jiang N; Xie B; Zhang X; He M; Li K; Bai J; Wang Z; He J; Zhang L
Cardiovasc Intervent Radiol; 2014 Oct; 37(5):1321-8. PubMed ID: 24549267
[TBL] [Abstract][Full Text] [Related]
28. Magnetic resonance-high intensity focused ultrasound (MR-HIFU) therapy of symptomatic uterine fibroids with unrestrictive treatment protocols: A systematic review and meta-analysis.
Verpalen IM; Anneveldt KJ; Nijholt IM; Schutte JM; Dijkstra JR; Franx A; Bartels LW; Moonen CTW; Edens MA; Boomsma MF
Eur J Radiol; 2019 Nov; 120():108700. PubMed ID: 31634683
[TBL] [Abstract][Full Text] [Related]
29. Oxytocin and Misoprostol With Diclofenac in the Preparation for Magnetic Resonance-Guided High-Intensity Ultrasound Treatment of Symptomatic Uterine Fibroids: A Prospective Cohort Study.
Łoziński T; Ludwin A; Filipowska J; Zgliczyńska M; Węgrzyn P; Kluz T; Ciebiera M
Ultrasound Med Biol; 2021 Jun; 47(6):1573-1585. PubMed ID: 33785226
[TBL] [Abstract][Full Text] [Related]
30. Volumetric ablation of uterine fibroids using Sonalleve high-intensity focused ultrasound in a 3 Tesla scanner--first clinical assessment.
Dorenberg EJ; Courivaud F; Ring E; Hald K; Jakobsen JÅ; Fosse E; Hol PK
Minim Invasive Ther Allied Technol; 2013 Apr; 22(2):73-9. PubMed ID: 22793778
[TBL] [Abstract][Full Text] [Related]
31. Intraprocedure contrast enhanced ultrasound: the value in assessing the effect of ultrasound-guided high intensity focused ultrasound ablation for uterine fibroids.
Peng S; Hu L; Chen W; Chen J; Yang C; Wang X; Zhang R; Wang Z; Zhang L
Ultrasonics; 2015 Apr; 58():123-8. PubMed ID: 25627929
[TBL] [Abstract][Full Text] [Related]
32. Evolution of the ablation region after magnetic resonance-guided high-intensity focused ultrasound ablation in a Vx2 tumor model.
Wijlemans JW; Deckers R; van den Bosch MA; Seinstra BA; van Stralen M; van Diest PJ; Moonen CT; Bartels LW
Invest Radiol; 2013 Jun; 48(6):381-6. PubMed ID: 23399810
[TBL] [Abstract][Full Text] [Related]
33. Pilot Study of the Mirabilis System Prototype for Rapid Noninvasive Uterine Myoma Treatment Using an Ultrasound-Guided Volumetric Shell Ablation Technique.
Parsons JE; Lau MPH; Martin PJ; Islas Lagos JJ; Aguilar Aguirre JM; Garza Leal JG
J Minim Invasive Gynecol; 2017; 24(4):579-591. PubMed ID: 28109895
[TBL] [Abstract][Full Text] [Related]
34. The Focused Ultrasound Myoma Outcome Study (FUMOS); a retrospective cohort study on long-term outcomes of MR-HIFU therapy.
Verpalen IM; de Boer JP; Linstra M; Pol RLI; Nijholt IM; Moonen CTW; Bartels LW; Franx A; Boomsma MF; Braat MNG
Eur Radiol; 2020 May; 30(5):2473-2482. PubMed ID: 32040725
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of single-dose gonadotropin-releasing hormone agonist administration prior to magnetic resonance-guided focused ultrasound surgery for symptomatic uterine fibroids.
Park H; Yoon SW
Radiol Med; 2017 Aug; 122(8):611-616. PubMed ID: 28341966
[TBL] [Abstract][Full Text] [Related]
36. A clinically feasible treatment protocol for magnetic resonance-guided high-intensity focused ultrasound ablation in the liver.
Wijlemans JW; de Greef M; Schubert G; Bartels LW; Moonen CT; van den Bosch MA; Ries M
Invest Radiol; 2015 Jan; 50(1):24-31. PubMed ID: 25198833
[TBL] [Abstract][Full Text] [Related]
37. Uterine leiomyomas: MR imaging-based thermometry and thermal dosimetry during focused ultrasound thermal ablation.
McDannold N; Tempany CM; Fennessy FM; So MJ; Rybicki FJ; Stewart EA; Jolesz FA; Hynynen K
Radiology; 2006 Jul; 240(1):263-72. PubMed ID: 16793983
[TBL] [Abstract][Full Text] [Related]
38. Efficacy, Efficiency, and Safety of Magnetic Resonance-Guided High-Intensity Focused Ultrasound for Ablation of Uterine Fibroids: Comparison with Ultrasound-Guided Method.
Wang Y; Wang ZB; Xu YH
Korean J Radiol; 2018; 19(4):724-732. PubMed ID: 29962878
[TBL] [Abstract][Full Text] [Related]
39. Preliminary study on ultrasound-guided high-intensity focused ultrasound ablation for treatment of broad ligament uterine fibroids.
Wang Y; Xu Y; Wong F; Wang Y; Cheng Y; Yang L
Int J Hyperthermia; 2021 Sep; 38(2):18-23. PubMed ID: 34420440
[TBL] [Abstract][Full Text] [Related]
40. The predictive value of quantitative DCE metrics for immediate therapeutic response of high-intensity focused ultrasound ablation (HIFU) of symptomatic uterine fibroids.
Wei C; Fang X; Wang CB; Chen Y; Xu X; Dong JN
Abdom Radiol (NY); 2018 Aug; 43(8):2169-2175. PubMed ID: 29204677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
